Abstract:BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly due in large part to age-dependent atrophy of retinal pigment epithelium (RPE) cells. RPE cells form a monolayer located between the choroid and the outer segments of photoreceptors, playing multifarious roles in maintenance of visual function. Allogeneically induced pluripotent stem cell-derived RPE (iPSC-RPE or iRPE) has become a potential approach for providing an abundant source of donors for clinical cell products. Transplantation of iRPE has been proven effective in rescuing impaired retinas in Royal College of Surgeons (RCS) rats after approximately 5 to 6 weeks. Here, we explore the long-term (19 weeks) safety and efficacy of human iRPE cell transplantation in pre-clinical animal models.METHODS: The expression of human RPE-specific markers in iRPE cells was determined using immunofluorescence staining. For the proliferative test, Ki-67 expression was also verified by immunofluorescence and flow cytometric analysis. Then, iRPE cells were transplanted into the subretinal space of immune-deficient NOD/SCID/IL-2Rgc<sup>null</sup> (NSG) mice to assess their safety. To evaluate whether the transplanted cells could survive and rescue visual function, we performed color fundus photography, focal electroretinogram and immunostaining after delivering iRPE cells into the subretinal space of RCS rats.RESULTS: Human iRPE cells expressed native RPE-specific markers, such as microphthalmia-associated transcription factor (MiTF), retinal pigment epithelium-specific 65-kDa protein (RPE65) and tight-junction associated structural protein (ZO-1), and their proliferative capacity (Ki-67 expression) was poor after 25 days of induction. A tumorigenicity test revealed no tumor formation or abnormal proliferation in the immunodeficient mice after subretinal injection of 5×10<sup>5</sup> iRPE cells. The transplanted iRPE cells survived for at least 19 weeks and maintained visual function for 15 weeks.CONCLUSIONS: In the present study, we provided further evidence for the use of human iRPE transplantation to treat retinal degenerative disease in pre-clinical animal models. Therefore, we consider human iRPE cells a promising source of cell replacement therapy for AMD.

Integration and Differentiation of Transplanted Human iPSC-Derived Retinal Ganglion Cell Precursors in Murine Retinas

Transplantation of Reprogrammed Peripheral Blood Cells Differentiates into Retinal Ganglion Cells in the Mouse Eye with NMDA-induced Injury

Enriching new transplantable RGC-like cells from retinal organoids for RGC replacement therapy

Transplantation of Retinal Progenitor Cells from Optic Cup-Like Structures Differentiated from Human Embryonic Stem Cells in Vitro and in Vivo Generation of Retinal Ganglion-Like Cells.

Directly induced human retinal ganglion cells mimic fetal RGCs and are neuroprotective after transplantation in vivo

Retinal Ganglion Cell Transplantation: Differentiation and Quantification Strategies

Generating ESC-Derived RGCs for Cell Replacement Therapy

Rapid and Efficient Generation of a Transplantable Population of Functional Retinal Ganglion Cells from Fibroblasts.

Biodegradable scaffolds facilitate epiretinal transplantation of hiPSC-Derived retinal neurons in nonhuman primates

The efficient induction of human retinal ganglion-like cells provides a platform for studying optic neuropathies

Protective effects of human iPS-derived retinal pigmented epithelial cells on retinal degenerative disease

Transplantation of retinal pigment epithelium and photoreceptors generated concomitantly via small molecule-mediated differentiation rescues visual function in rodent models of retinal degeneration

Stage-specific Differentiation of Ipscs Toward Retinal Ganglion Cell Lineage.

Human iPSC-derived Microglial Cells Integrated into Mouse Retina and Recapitulated Features of Endogenous Microglia

Transplantation of GMP-grade human iPSC-derived retinal pigment epithelial cells in rodent model: the first pre-clinical study for safety and efficacy in China

Transplantable and functional retinal pigment epithelium derived from non-colony-type monolayer of human induced pluripotent stem cells

Hipsc-Derived Retinal Ganglion Cells Grow Dendritic Arbors and Functional Axons on A Tissue-Engineered Scaffold

In vivo Regeneration of Ganglion Cells for Vision Restoration in Mammalian Retinas

Human Retinal Progenitor Cell Transplantation Preserves Vision.

Biocompatible neuronal stimulant-embedded poly(γ-benzyl-L-glutamate) peptide-based scaffolds promote differentiation, growth and functional maturation of human induced pluripotent stem cell-derived retinal ganglion cells

Establishing Functional Retina in a Dish: Progress and Promises of Induced Pluripotent Stem Cell-Based Retinal Neuron Differentiation